{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T02:43:32Z","timestamp":1789872212299,"version":"4.0.1"},"reference-count":114,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:00:00Z","timestamp":1759536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:00:00Z","timestamp":1759536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-11081-2","type":"journal-article","created":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:50:47Z","timestamp":1759567847000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Unraveling the multifactorial pathophysiology of polycystic ovary syndrome: exploring lifestyle, prenatal influences, neuroendocrine dysfunction, and post-translational modifications"],"prefix":"10.1007","volume":"52","author":[{"given":"Harshini","family":"Senthilkumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhash C.","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohanapriya","family":"Arumugam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,4]]},"reference":[{"issue":"12","key":"11081_CR1","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1093\/humrep\/dew218","volume":"31","author":"G Bozdag","year":"2016","unstructured":"Bozdag G et al (2016) The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod 31(12):2841\u20132855. https:\/\/doi.org\/10.1093\/humrep\/dew218","journal-title":"Hum Reprod"},{"issue":"1","key":"11081_CR2","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1186\/s12967-025-06315-7","volume":"23","author":"H Senthilkumar","year":"2025","unstructured":"Senthilkumar H, Arumugam M (2025) Gut microbiota: a hidden player in polycystic ovary syndrome. J Transl Med 23(1):443. https:\/\/doi.org\/10.1186\/s12967-025-06315-7","journal-title":"J Transl Med"},{"issue":"1","key":"11081_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12958-020-00687-9","volume":"19","author":"L Mu","year":"2021","unstructured":"Mu L, Sun X, Tu M, Zhang D (2021) Non-coding RNAs in polycystic ovary syndrome: a systematic review and meta-analysis. Reproductive Biology Endocrinology: RB&E 19(1):10. https:\/\/doi.org\/10.1186\/s12958-020-00687-9","journal-title":"Reproductive Biology Endocrinology: RB&E"},{"issue":"23","key":"11081_CR4","doi-asserted-by":"publisher","first-page":"9815","DOI":"10.1074\/jbc.M117.783886","volume":"292","author":"E Stern","year":"2017","unstructured":"Stern E, Ruf-Zamojski F, Zalepa-King L, Pincas H, Choi SG, Peskin CS, Hayot F, Turgeon JL, Sealfon SC (2017) Modeling and high-throughput experimental data uncover the mechanisms underlying Fshb gene sensitivity to gonadotropin-releasing hormone pulse frequency. J Biol Chem 292(23):9815\u20139829. https:\/\/doi.org\/10.1074\/jbc.M117.783886","journal-title":"J Biol Chem"},{"issue":"1","key":"11081_CR5","doi-asserted-by":"publisher","first-page":"7085","DOI":"10.1038\/s41598-021-86697-y","volume":"11","author":"YB Won","year":"2021","unstructured":"Won YB, Seo SK, Yun BH, Cho S, Choi YS, Lee BS (2021) Non-alcoholic fatty liver disease in polycystic ovary syndrome women. Sci Rep 11(1):7085. https:\/\/doi.org\/10.1038\/s41598-021-86697-y","journal-title":"Sci Rep"},{"issue":"3","key":"11081_CR6","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/cen.13919","volume":"90","author":"E Oberg","year":"2019","unstructured":"Oberg E, Gidl\u00f6f S, Jakson I, Mitsell M, Egnell T, P., Hirschberg AL (2019) Improved menstrual function in obese women with polycystic ovary syndrome after behavioural modification intervention-A randomized controlled trial. Clin Endocrinol 90(3):468\u2013478. https:\/\/doi.org\/10.1111\/cen.13919","journal-title":"Clin Endocrinol"},{"key":"11081_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/fendo.2019.00023","volume":"10","author":"JSE Laven","year":"2019","unstructured":"Laven JSE (2019) Follicle stimulating hormone receptor (FSHR) polymorphisms and polycystic ovary syndrome (PCOS). Front Endocrinol 10:23. https:\/\/doi.org\/10.3389\/fendo.2019.00023","journal-title":"Front Endocrinol"},{"issue":"11","key":"11081_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20112720","volume":"20","author":"Y Ryu","year":"2019","unstructured":"Ryu Y, Kim SW, Kim YY, Ku SY (2019) Animal models for human polycystic ovary syndrome (PCOS) focused on the use of indirect hormonal perturbations: a review of the literature. Int J Mol Sci 20(11):2720. https:\/\/doi.org\/10.3390\/ijms20112720","journal-title":"Int J Mol Sci"},{"key":"11081_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.735684","volume":"9","author":"J Li","year":"2021","unstructured":"Li J, Chen H, Gou M, Tian C, Wang H, Song X, Keefe DL, Bai X, Liu L (2021) Molecular features of polycystic ovary syndrome revealed by transcriptome analysis of oocytes and cumulus cells. Front Cell Dev Biol 9:735684. https:\/\/doi.org\/10.3389\/fcell.2021.735684","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"11081_CR10","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1093\/biolre\/ioaa119","volume":"103","author":"M Liu","year":"2020","unstructured":"Liu M, Hummitzsch K, Hartanti MD, Rosario R, Bastian NA, Hatzirodos N, Bonner WM, Irving-Rodgers HF, Laven JSE, Anderson RA, Rodgers RJ (2020) Analysis of expression of candidate genes for polycystic ovary syndrome in adult and fetal human and fetal bovine ovaries\u2020. Biol Reprod 103(4):840\u2013853. https:\/\/doi.org\/10.1093\/biolre\/ioaa119","journal-title":"Biol Reprod"},{"issue":"8","key":"11081_CR11","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1089\/dna.2019.5172","volume":"39","author":"X Zeng","year":"2020","unstructured":"Zeng X, Huang Q, Long SL, Zhong Q, Mo Z (2020) Mitochondrial dysfunction in polycystic ovary syndrome. DNA Cell Biol 39(8):1401\u20131409. https:\/\/doi.org\/10.1089\/dna.2019.5172","journal-title":"DNA Cell Biol"},{"issue":"1","key":"11081_CR12","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13048-022-00962-w","volume":"15","author":"J Zou","year":"2022","unstructured":"Zou J, Li Y, Liao N, Liu J, Zhang Q, Luo M, Xiao J, Chen Y, Wang M, Chen K, Zeng J, Mo Z (2022) Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis. J Ovarian Res 15(1):30. https:\/\/doi.org\/10.1186\/s13048-022-00962-w","journal-title":"J Ovarian Res"},{"key":"11081_CR13","doi-asserted-by":"publisher","first-page":"755741","DOI":"10.3389\/fcimb.2021.755741","volume":"11","author":"C Lu","year":"2021","unstructured":"Lu C, Wang H, Yang J, Zhang X, Chen Y, Feng R, Qian Y (2021) Changes in vaginal microbiome diversity in women with polycystic ovary syndrome. Front Cell Infect Microbiol 11:755741. https:\/\/doi.org\/10.3389\/fcimb.2021.755741","journal-title":"Front Cell Infect Microbiol"},{"issue":"3","key":"11081_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.repbio.2023.100787","volume":"23","author":"K Patil","year":"2023","unstructured":"Patil K, Naigaonkar A, Hinduja I, Mukherjee S (2023) Transcriptomic profile of GLCs of PCOS women highlights metabolic dysregulation as a plausible contributor to PCOS pathophysiology. Reprod Biol 23(3):100787. https:\/\/doi.org\/10.1016\/j.repbio.2023.100787","journal-title":"Reprod Biol"},{"issue":"1","key":"11081_CR15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13048-025-01642-1","volume":"18","author":"L Wang","year":"2025","unstructured":"Wang L, Jin Y, Zhi Y, Li Z, Wang M, Wang B, Wang X (2025) Effects of melatonin in polycystic ovary syndrome: is there Hippo pathway crosstalk? J Ovarian Res 18(1):101. https:\/\/doi.org\/10.1186\/s13048-025-01642-1","journal-title":"J Ovarian Res"},{"key":"11081_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12958-025-01396-x","volume":"23","author":"W Shi","year":"2025","unstructured":"Shi W, Lin H, Di W et al (2025) Granulosa cell RNA-Seq insights into senescence and sphingolipid metabolism disorder in PCOS: aspirin as a potential therapeutic drug. Reprod Biol Endocrinol 23:61. https:\/\/doi.org\/10.1186\/s12958-025-01396-x","journal-title":"Reprod Biol Endocrinol"},{"key":"11081_CR17","doi-asserted-by":"publisher","first-page":"106795","DOI":"10.1016\/j.jsbmb.2025.10679","volume":"253","author":"H Senthilkumar","year":"2025","unstructured":"Senthilkumar H, Arumugam M (2025) Untangling hidden players of PCOS: from transcriptomics to key biomarkers using WGCNA, LASSO and ROC analysis. J Steroid Biochem Mol Biol 253:106795 Advance online publication. https:\/\/doi.org\/10.1016\/j.jsbmb.2025.10679","journal-title":"J Steroid Biochem Mol Biol"},{"key":"11081_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116522","volume":"229","author":"N Virtanen","year":"2024","unstructured":"Virtanen N, Saarela U, Karpale M, Arffman RK, M\u00e4kel\u00e4 KA, Herzig KH, Koivunen P, Piltonen T (2024) Roxadustat alleviates metabolic traits in letrozole-induced PCOS mice. Biochem Pharmacol 229:116522. https:\/\/doi.org\/10.1016\/j.bcp.2024.116522","journal-title":"Biochem Pharmacol"},{"key":"11081_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155456","volume":"128","author":"S He","year":"2024","unstructured":"He S, Li H, Zhang Q, Zhao W, Li W, Dai C, Li B, Cheng J, Wu S, Zhou Z, Yang J, Li S (2024) Berberine alleviates inflammation in polycystic ovary syndrome by inhibiting hyaluronan synthase 2 expression. Phytomedicine 128:155456. https:\/\/doi.org\/10.1016\/j.phymed.2024.155456","journal-title":"Phytomedicine"},{"issue":"6","key":"11081_CR20","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/s41591-018-0035-5","volume":"24","author":"B Tata","year":"2018","unstructured":"Tata B, Mimouni NEH, Barbotin AL, Malone SA, Loyens A, Pigny P, Dewailly D, Catteau-Jonard S, Sundstr\u00f6m-Poromaa I, Piltonen TT, Bello D, Medana F, Prevot C, Clasadonte V, J., Giacobini P (2018) Elevated prenatal anti-M\u00fcllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood. Nat Med 24(6):834\u2013846. https:\/\/doi.org\/10.1038\/s41591-018-0035-5","journal-title":"Nat Med"},{"issue":"6","key":"11081_CR21","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1210\/jc.2010-2618","volume":"96","author":"PA Fowler","year":"2011","unstructured":"Fowler PA, Anderson RA, Saunders PT, Kinnell H, Mason JI, Evans DB, Bhattacharya S, Flannigan S, Franks S, Monteiro A, O\u2019Shaughnessy PJ (2011) Development of steroid signaling pathways during primordial follicle formation in the human fetal ovary. J Clin Endocrinol Metab 96(6):1754\u20131762. https:\/\/doi.org\/10.1210\/jc.2010-2618","journal-title":"J Clin Endocrinol Metab"},{"key":"11081_CR22","doi-asserted-by":"publisher","first-page":"452","DOI":"10.3389\/fendo.2018.00452","volume":"9","author":"S Franks","year":"2018","unstructured":"Franks S, Hardy K (2018) Androgen action in the ovary. Front Endocrinol 9:452. https:\/\/doi.org\/10.3389\/fendo.2018.00452","journal-title":"Front Endocrinol"},{"issue":"36","key":"11081_CR23","doi-asserted-by":"publisher","first-page":"e2309429","DOI":"10.1002\/advs.202309429","volume":"11","author":"H Lu","year":"2024","unstructured":"Lu H, Jiang H, Li C, Derisoud E, Zhao A, Eriksson G, Lindgren E, Pui H, Risal S, Pei Y, Maxian T, Ohlsson C, Benrick A, Haider S, Stener-Victorin E, Deng Q (2024) Dissecting the impact of maternal androgen exposure on developmental programming through targeting the androgen receptor. Adv Sci (Weinheim Baden-Wurttemberg Germany) 11(36):e2309429. https:\/\/doi.org\/10.1002\/advs.202309429","journal-title":"Adv Sci (Weinheim Baden-Wurttemberg Germany)"},{"key":"11081_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1365624","volume":"12","author":"A Kusamoto","year":"2024","unstructured":"Kusamoto A, Harada M, Minemura A, Matsumoto A, Oka K, Takahashi M, Sakaguchi N, Azhary JMK, Koike H, Xu Z, Tanaka T, Urata Y, Kunitomi C, Takahashi N, Wada-Hiraike O, Hirota Y, Osuga Y (2024) Effects of the prenatal and postnatal nurturing environment on the phenotype and gut microbiota of mice with polycystic ovary syndrome induced by prenatal androgen exposure: a cross-fostering study. Front Cell Dev Biol 12:1365624. https:\/\/doi.org\/10.3389\/fcell.2024.1365624","journal-title":"Front Cell Dev Biol"},{"key":"11081_CR25","doi-asserted-by":"publisher","first-page":"117955142311964","DOI":"10.1177\/11795514231196461","volume":"16","author":"GA Abruzzese","year":"2023","unstructured":"Abruzzese GA, Ferreira SR, Ferrer MJ, Silva AF, Motta AB (2023) Prenatal androgen excess induces multigenerational effects on female and male descendants. Clin Med Insights Endocrinol Diabetes 16:11795514231196461. https:\/\/doi.org\/10.1177\/11795514231196461","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"key":"11081_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2020.110913","volume":"514","author":"X Guo","year":"2020","unstructured":"Guo X, Puttabyatappa M, Domino SE, Padmanabhan V (2020) Developmental programming: prenatal testosterone-induced changes in epigenetic modulators and gene expression in metabolic tissues of female sheep. Mol Cell Endocrinol 514:110913. https:\/\/doi.org\/10.1016\/j.mce.2020.110913","journal-title":"Mol Cell Endocrinol"},{"key":"11081_CR27","doi-asserted-by":"publisher","unstructured":"Risal, S., Pei, Y., Lu, H., Manti, M., Fornes, R., Pui, H. P., Zhao, Z., Massart,J., Ohlsson, C., Lindgren, E., Crisosto, N., Maliqueo, M., Echibur\u00fa, B., Ladr\u00f3n de Guevara, A., Sir-Petermann, T., Larsson, H., Rosenqvist, M. A., Cesta, C. E., Benrick,A., Deng, Q., \u2026 Stener-Victorin, E. (2019). Prenatal androgen exposure and transgenerational susceptibility to polycystic ovary syndrome. Nature medicine, 25(12), 1894\u20131904. https:\/\/doi.org\/10.1038\/s41591-019-0666-1","DOI":"10.1038\/s41591-019-0666-1"},{"issue":"4","key":"11081_CR28","doi-asserted-by":"publisher","first-page":"887","DOI":"10.5114\/aoms.2019.86060","volume":"15","author":"E Hosseini","year":"2019","unstructured":"Hosseini E, Shahhoseini M, Afsharian P, Karimian L, Ashrafi M, Mehraein F, Afatoonian R (2019) Role of epigenetic modifications in the aberrant CYP19A1 gene expression in polycystic ovary syndrome. Arch Med Sci 15(4):887\u2013895. https:\/\/doi.org\/10.5114\/aoms.2019.86060","journal-title":"Arch Med Sci"},{"issue":"2","key":"11081_CR29","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1080\/19396368.2018.1537385","volume":"65","author":"L Detti","year":"2019","unstructured":"Detti L, Christiansen ME, Francillon L, Ikuwezunma G, Diamond MP, Mari G, Tobiasz AM (2019) Serum anti-M\u00fcllerian hormone (AMH) in mothers with polycystic ovary syndrome (PCOS) and their term fetuses. Syst Biol Reprod Med 65(2):147\u2013154. https:\/\/doi.org\/10.1080\/19396368.2018.1537385","journal-title":"Syst Biol Reprod Med"},{"issue":"9389","key":"11081_CR30","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/s0140-6736(03)14410-8","volume":"362","author":"LJ Webber","year":"2003","unstructured":"Webber LJ, Stubbs S, Stark J, Trew GH, Margara R, Hardy K, Franks S (2003) Formation and early development of follicles in the polycystic ovary. Lancet (London England) 362(9389):1017\u20131021. https:\/\/doi.org\/10.1016\/s0140-6736(03)14410-8","journal-title":"Lancet (London England)"},{"issue":"3","key":"11081_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007506.pub4","volume":"3","author":"SS Lim","year":"2019","unstructured":"Lim SS, Hutchison SK, Van Ryswyk E, Norman RJ, Teede HJ, Moran LJ (2019) Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev 3(3):CD007506. https:\/\/doi.org\/10.1002\/14651858.CD007506.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"11081_CR32","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12978-024-01758-5","volume":"21","author":"AE Juh\u00e1sz","year":"2024","unstructured":"Juh\u00e1sz AE, Stubnya MP, Teutsch B et al (2024) Ranking the dietary interventions by their effectiveness in the management of polycystic ovary syndrome: a systematic review and network meta-analysis. Reprod Health 21:28. https:\/\/doi.org\/10.1186\/s12978-024-01758-5","journal-title":"Reprod Health"},{"issue":"16","key":"11081_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13164934","volume":"13","author":"SA Alenezi","year":"2024","unstructured":"Alenezi SA, Elkmeshi N, Alanazi A, Alanazi ST, Khan R, Amer S (2024) The impact of diet-induced weight loss on inflammatory status and hyperandrogenism in women with polycystic ovarian syndrome (PCOS)-a systematic review and meta-analysis. J Clin Med 13(16):4934. https:\/\/doi.org\/10.3390\/jcm13164934","journal-title":"J Clin Med"},{"issue":"4","key":"11081_CR34","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.fertnstert.2016.08.031","volume":"106","author":"AZ Rutkowska","year":"2016","unstructured":"Rutkowska AZ, Diamanti-Kandarakis E (2016) Polycystic ovary syndrome and environmental toxins. Fertil Steril 106(4):948\u2013958. https:\/\/doi.org\/10.1016\/j.fertnstert.2016.08.031","journal-title":"Fertil Steril"},{"issue":"12","key":"11081_CR35","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.3390\/nu7125524","volume":"7","author":"D Garg","year":"2015","unstructured":"Garg D, Merhi Z (2015) Advanced glycation end products: link between diet and ovulatory dysfunction in PCOS? Nutrients 7(12):10129\u201310144. https:\/\/doi.org\/10.3390\/nu7125524","journal-title":"Nutrients"},{"key":"11081_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2024.108562","volume":"125","author":"J Patel","year":"2024","unstructured":"Patel J, Chaudhary H, Panchal S, Joshi T, Joshi R (2024) Endocrine-disrupting chemicals and hormonal profiles in PCOS women: a comparative study between urban and rural environment. Reprod Toxicol 125:108562. https:\/\/doi.org\/10.1016\/j.reprotox.2024.108562","journal-title":"Reprod Toxicol"},{"issue":"1","key":"11081_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.repbio.2024.100993","volume":"25","author":"AS Ambekar","year":"2025","unstructured":"Ambekar AS, Naredi N, Malakar D, Vashum Y, Misra P, Kulkarni M (2025) Early and advanced glycation end product analysis from women with PCOS on Metformin. Reprod Biol 25(1):100993. https:\/\/doi.org\/10.1016\/j.repbio.2024.100993","journal-title":"Reprod Biol"},{"issue":"4","key":"11081_CR38","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/cen.14153","volume":"92","author":"A Thannickal","year":"2020","unstructured":"Thannickal A, Brutocao C, Alsawas M, Morrow A, Zaiem F, Murad MH, Chattha J, A (2020) Eating, sleeping and sexual function disorders in women with polycystic ovary syndrome (PCOS): A systematic review and meta-analysis. Clin Endocrinol 92(4):338\u2013349. https:\/\/doi.org\/10.1111\/cen.14153","journal-title":"Clin Endocrinol"},{"issue":"5","key":"11081_CR39","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1093\/humrep\/dex044","volume":"32","author":"LG Cooney","year":"2017","unstructured":"Cooney LG, Lee I, Sammel MD, Dokras A (2017) High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod (Oxford England) 32(5):1075\u20131091. https:\/\/doi.org\/10.1093\/humrep\/dex044","journal-title":"Hum Reprod (Oxford England)"},{"issue":"3","key":"11081_CR40","doi-asserted-by":"publisher","first-page":"239","DOI":"10.4103\/IJPSYM.IJPSYM_561_17","volume":"40","author":"AP Chaudhari","year":"2018","unstructured":"Chaudhari AP, Mazumdar K, Mehta PD (2018) Anxiety, depression, and quality of life in women with polycystic ovarian syndrome. Indian J Psychol Med 40(3):239\u2013246. https:\/\/doi.org\/10.4103\/IJPSYM.IJPSYM_561_17","journal-title":"Indian J Psychol Med"},{"issue":"2","key":"11081_CR41","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1007\/s12020-018-1692-3","volume":"62","author":"C Brutocao","year":"2018","unstructured":"Brutocao C, Zaiem F, Alsawas M, Morrow AS, Murad MH, Javed A (2018) Psychiatric disorders in women with polycystic ovary syndrome: a systematic review and meta-analysis. Endocrine 62(2):318\u2013325. https:\/\/doi.org\/10.1007\/s12020-018-1692-3","journal-title":"Endocrine"},{"key":"11081_CR42","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1186\/1472-6882-14-511","volume":"14","author":"S Arentz","year":"2014","unstructured":"Arentz S, Abbott JA, Smith CA, Bensoussan A (2014) Herbal medicine for the management of polycystic ovary syndrome (PCOS) and associated oligo\/amenorrhoea and hyperandrogenism; a review of the laboratory evidence for effects with corroborative clinical findings. BMC Complement Altern Med 14:511. https:\/\/doi.org\/10.1186\/1472-6882-14-511","journal-title":"BMC Complement Altern Med"},{"issue":"13","key":"11081_CR43","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1080\/14656566.2016.1215430","volume":"17","author":"D Armanini","year":"2016","unstructured":"Armanini D, Andrisani A, Bordin L, Sabbadin C (2016) Spironolactone in the treatment of polycystic ovary syndrome. Expert Opin Pharmacother 17(13):1713\u20131715. https:\/\/doi.org\/10.1080\/14656566.2016.1215430","journal-title":"Expert Opin Pharmacother"},{"key":"11081_CR44","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2147\/IJWH.S11304","volume":"3","author":"A Badawy","year":"2011","unstructured":"Badawy A, Elnashar A (2011) Treatment options for polycystic ovary syndrome. Int J Womens Health 3:25\u201335. https:\/\/doi.org\/10.2147\/IJWH.S11304","journal-title":"Int J Womens Health"},{"issue":"3","key":"11081_CR45","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1210\/jcem.81.3.8772555","volume":"81","author":"A Dunaif","year":"1996","unstructured":"Dunaif A, Finegood DT (1996) Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J Clin Endocrinol Metab 81(3):942\u2013947. https:\/\/doi.org\/10.1210\/jcem.81.3.8772555","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"11081_CR46","doi-asserted-by":"publisher","first-page":"3970","DOI":"10.1210\/jc.2005-2250","volume":"91","author":"A Gambineri","year":"2006","unstructured":"Gambineri A, Patton L, Vaccina A, Cacciari M, Morselli-Labate AM, Cavazza C, Pagotto U, Pasquali R (2006) Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study. J Clin Endocrinol Metab 91(10):3970\u20133980. https:\/\/doi.org\/10.1210\/jc.2005-2250","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"11081_CR47","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/j.1365-2265.1986.tb03620.x","volume":"25","author":"P Petsos","year":"1986","unstructured":"Petsos P, Ratcliffe WA, Anderson DC (1986) Effects of medroxyprogesterone acetate in women with polycystic ovary syndrome. Clin Endocrinol 25(6):651\u2013660. https:\/\/doi.org\/10.1111\/j.1365-2265.1986.tb03620.x","journal-title":"Clin Endocrinol"},{"issue":"2","key":"11081_CR48","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1177\/193229680700100212","volume":"1","author":"CA Steiner","year":"2007","unstructured":"Steiner CA, Janez A, Jensterle M, Reisinger K, Forst T, Pf\u00fctzner A (2007) Impact of treatment with Rosiglitazone or Metformin on biomarkers for insulin resistance and metabolic syndrome in patients with polycystic ovary syndrome. J Diabetes Sci Technol 1(2):211\u2013217. https:\/\/doi.org\/10.1177\/193229680700100212","journal-title":"J Diabetes Sci Technol"},{"issue":"4","key":"11081_CR49","doi-asserted-by":"publisher","first-page":"255","DOI":"10.4103\/0974-1208.147492","volume":"7","author":"P Kumar","year":"2014","unstructured":"Kumar P, Arora S (2014) Orlistat in polycystic ovarian syndrome reduces weight with improvement in lipid profile and pregnancy rates. J Hum Reprod Sci 7(4):255\u2013261. https:\/\/doi.org\/10.4103\/0974-1208.147492","journal-title":"J Hum Reprod Sci"},{"key":"11081_CR50","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3389\/fendo.2014.00140","volume":"5","author":"CB Rasmussen","year":"2014","unstructured":"Rasmussen CB, Lindenberg S (2014) The effect of liraglutide on weight loss in women with polycystic ovary syndrome: an observational study. Front Endocrinol 5:140. https:\/\/doi.org\/10.3389\/fendo.2014.00140","journal-title":"Front Endocrinol"},{"issue":"3","key":"11081_CR51","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1093\/humupd\/dms059","volume":"19","author":"M Murri","year":"2013","unstructured":"Murri M, Luque-Ram\u00edrez M, Insenser M, Ojeda-Ojeda M, Escobar-Morreale HF (2013) Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Hum Reprod Update 19(3):268\u2013288. https:\/\/doi.org\/10.1093\/humupd\/dms059","journal-title":"Hum Reprod Update"},{"issue":"6","key":"11081_CR52","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1093\/humrep\/16.6.1255","volume":"16","author":"S Kirchengast","year":"2001","unstructured":"Kirchengast S, Huber J (2001) Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome. Hum Reprod (Oxford England) 16(6):1255\u20131260. https:\/\/doi.org\/10.1093\/humrep\/16.6.1255","journal-title":"Hum Reprod (Oxford England)"},{"issue":"12","key":"11081_CR53","doi-asserted-by":"publisher","first-page":"6454","DOI":"10.1210\/jc.2004-2438","volume":"90","author":"C Couillard","year":"2005","unstructured":"Couillard C, Ruel G, Archer WR, Pomerleau S, Bergeron J, Couture P, Lamarche B, Bergeron N (2005) Circulating levels of oxidative stress markers and endothelial adhesion molecules in men with abdominal obesity. J Clin Endocrinol Metab 90(12):6454\u20136459. https:\/\/doi.org\/10.1210\/jc.2004-2438","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"11081_CR54","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1194\/jlr.M700199-JLR200","volume":"49","author":"R MacLaren","year":"2008","unstructured":"MacLaren R, Cui W, Simard S, Cianflone K (2008) Influence of obesity and insulin sensitivity on insulin signaling genes in human omental and subcutaneous adipose tissue. J Lipid Res 49(2):308\u2013323. https:\/\/doi.org\/10.1194\/jlr.M700199-JLR200","journal-title":"J Lipid Res"},{"issue":"8","key":"11081_CR55","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1210\/jc.2012-1259","volume":"97","author":"F Gonz\u00e1lez","year":"2012","unstructured":"Gonz\u00e1lez F, Nair KS, Daniels JK, Basal E, Schimke JM, Blair HE (2012) Hyperandrogenism sensitizes leukocytes to hyperglycemia to promote oxidative stress in lean reproductive-age women. J Clin Endocrinol Metab 97(8):2836\u20132843. https:\/\/doi.org\/10.1210\/jc.2012-1259","journal-title":"J Clin Endocrinol Metab"},{"key":"11081_CR56","doi-asserted-by":"publisher","unstructured":"Keane KN, Cruzat VF, Carlessi R, de Bittencourt PI Jr, Newsholme P (2015) Molecular Events Linking Oxidative Stress and Inflammation to Insulin Resistance and \u03b2-Cell Dysfunction. Oxidative medicine and cellular longevity, 2015, 181643. https:\/\/doi.org\/10.1155\/2015\/181643","DOI":"10.1155\/2015\/181643"},{"key":"11081_CR57","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s43042-023-00418-w","volume":"24","author":"T Bhimwal","year":"2023","unstructured":"Bhimwal T, Puneet, Priyadarshani A (2023) Understanding polycystic ovary syndrome in light of associated key genes. Egypt J Med Hum Genet 24:38. https:\/\/doi.org\/10.1186\/s43042-023-00418-w","journal-title":"Egypt J Med Hum Genet"},{"key":"11081_CR58","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12958-024-01337-0","volume":"22","author":"H Yan","year":"2024","unstructured":"Yan H, Wang L, Zhang G et al (2024) Oxidative stress and energy metabolism abnormalities in polycystic ovary syndrome: from mechanisms to therapeutic strategies. Reprod Biol Endocrinol 22:159. https:\/\/doi.org\/10.1186\/s12958-024-01337-0","journal-title":"Reprod Biol Endocrinol"},{"key":"11081_CR59","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13048-024-01422-3","volume":"17","author":"A Abdi","year":"2024","unstructured":"Abdi A, Ranjbaran M, Amidi F et al (2024) The effect of adipose-derived mesenchymal stem cell transplantation on ovarian mitochondrial dysfunction in letrozole-induced polycystic ovary syndrome in rats: the role of PI3K-AKT signaling pathway. J Ovarian Res 17:91. https:\/\/doi.org\/10.1186\/s13048-024-01422-3","journal-title":"J Ovarian Res"},{"key":"11081_CR60","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.923073","volume":"26","author":"J Xu","year":"2020","unstructured":"Xu J, Dun J, Yang J, Zhang J, Lin Q, Huang M, Ji F, Huang L, You X, Lin Y (2020) Letrozole rat model mimics human polycystic ovarian syndrome and changes in insulin signal pathways. Med Sci Monit 26:e923073. https:\/\/doi.org\/10.12659\/MSM.923073","journal-title":"Med Sci Monit"},{"key":"11081_CR61","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13048-023-01334-8","volume":"17","author":"NX Jiang","year":"2024","unstructured":"Jiang NX, Zhao WJ, Shen HR et al (2024) Hyperinsulinemia impairs decidualization via AKT-NR4A1 signaling: new insight into polycystic ovary syndrome (PCOS)-related infertility. J Ovarian Res 17:31. https:\/\/doi.org\/10.1186\/s13048-023-01334-8","journal-title":"J Ovarian Res"},{"issue":"4","key":"11081_CR62","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s12522-010-0062-5","volume":"9","author":"T Sakumoto","year":"2010","unstructured":"Sakumoto T, Tokunaga Y, Tanaka H, Nohara M, Motegi E, Shinkawa T, Nakaza A, Higashi M (2010) Insulin resistance\/hyperinsulinemia and reproductive disorders in infertile women. Reprod Med Biol 9(4):185\u2013190. https:\/\/doi.org\/10.1007\/s12522-010-0062-5","journal-title":"Reprod Med Biol"},{"issue":"3","key":"11081_CR63","doi-asserted-by":"publisher","first-page":"e0119995","DOI":"10.1371\/journal.pone.0119995","volume":"10","author":"SA DiVall","year":"2015","unstructured":"DiVall SA, Herrera D, Sklar B, Wu S, Wondisford F, Radovick S, Wolfe A (2015) Insulin receptor signaling in the GnRH neuron plays a role in the abnormal GnRH pulsatility of obese female mice. PLoS ONE 10(3):e0119995. https:\/\/doi.org\/10.1371\/journal.pone.0119995","journal-title":"PLoS ONE"},{"issue":"2","key":"11081_CR64","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-24-0269","volume":"265","author":"EJ Houston","year":"2025","unstructured":"Houston EJ, Templeman NM (2025) Reappraising the relationship between hyperinsulinemia and insulin resistance in PCOS. J Endocrinol 265(2):e240269. https:\/\/doi.org\/10.1530\/JOE-24-0269","journal-title":"J Endocrinol"},{"issue":"1","key":"11081_CR65","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1210\/jc.2005-1329","volume":"91","author":"DA Ehrmann","year":"2006","unstructured":"Ehrmann DA, Liljenquist DR, Kasza K, Azziz R, Legro RS, Ghazzi MN, Troglitazone Study Group (2006) Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 91(1):48\u201353. https:\/\/doi.org\/10.1210\/jc.2005-1329","journal-title":"J Clin Endocrinol Metab"},{"key":"11081_CR66","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1016\/j.endmts.2025.100228","volume":"17","author":"M Arghavan Ghafari","year":"2025","unstructured":"Arghavan Ghafari M, Maftoohi ME, Samarin S, Barani M, Banimohammad R, Samie (2025) The last update on polycystic ovary syndrome(PCOS), diagnosis criteria, and novel treatment. Endocr Metabolic Sci 17:2666\u20133961. https:\/\/doi.org\/10.1016\/j.endmts.2025.100228","journal-title":"Endocr Metabolic Sci"},{"issue":"1","key":"11081_CR67","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/ng.732","volume":"43","author":"ZJ Chen","year":"2011","unstructured":"Chen ZJ, Zhao H, He L, Shi Y, Qin Y, Shi Y, Li Z, You L, Zhao J, Liu J, Liang X, Zhao X, Zhao J, Sun Y, Zhang B, Jiang H, Zhao D, Bian Y, Gao X, Geng L, Li Yiran, Zhu Dongyi, Sun Xiuqin, Xu Jin-e, Hao Cuifang, Ren Chun-e, Zhang Yajie, Chen Shiling, Zhang Wei, Yang Aijun, Yan Junhao, Ma Jinlong, Zhao Y (2011) Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat Genet 43(1):55\u201359. https:\/\/doi.org\/10.1038\/ng.732","journal-title":"Nat Genet"},{"key":"11081_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.01.001","volume":"35","author":"MA Sanchez-Garrido","year":"2020","unstructured":"Sanchez-Garrido MA, Tena-Sempere M (2020) Metabolic dysfunction in polycystic ovary syndrome: pathogenic role of androgen excess and potential therapeutic strategies. Mol Metab 35:100937. https:\/\/doi.org\/10.1016\/j.molmet.2020.01.001","journal-title":"Mol Metab"},{"key":"11081_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2019.110561","volume":"498","author":"C Coyle","year":"2019","unstructured":"Coyle C, Campbell RE (2019) Pathological pulses in PCOS. Mol Cell Endocrinol 498:110561. https:\/\/doi.org\/10.1016\/j.mce.2019.110561","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"11081_CR70","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1055\/s-0041-1731379","volume":"43","author":"SF Medeiros","year":"2021","unstructured":"Medeiros SF, Barbosa BB, Medeiros MAS, Yamamoto MMW (2021) Morphology and biochemistry of Ovulation. Morfologia e bioqu\u00edmica Da ovula\u00e7\u00e3o. Revista Brasileira De Ginecol E Obstetricia: Revista Da Federacao Brasileira Das Sociedades De Ginecol E Obstet 43(6):480\u2013486. https:\/\/doi.org\/10.1055\/s-0041-1731379","journal-title":"Revista Brasileira De Ginecol E Obstetricia: Revista Da Federacao Brasileira Das Sociedades De Ginecol E Obstet"},{"key":"11081_CR71","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/4071735","volume":"2016","author":"H Mobeen","year":"2016","unstructured":"Mobeen H, Afzal N, Kashif M (2016) Polycystic ovary syndrome may be an autoimmune disorder. Scientifica 2016:4071735. https:\/\/doi.org\/10.1155\/2016\/4071735","journal-title":"Scientifica"},{"key":"11081_CR72","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.97179","volume":"13","author":"Z Zhou","year":"2025","unstructured":"Zhou Z, Han SY, Pardo-Navarro M, Wall EG, Desai R, Vas S, Handelsman DJ, Herbison AE (2025) GnRH pulse generator activity in mouse models of polycystic ovary syndrome. eLife 13:RP97179. https:\/\/doi.org\/10.7554\/eLife.97179","journal-title":"eLife"},{"key":"11081_CR73","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.coemr.2020.04.005","volume":"12","author":"CR McCartney","year":"2020","unstructured":"McCartney CR, Campbell RE (2020) Abnormal GnRH pulsatility in polycystic ovary syndrome: recent insights. Curr Opin Endocr Metab Res 12:78\u201384. https:\/\/doi.org\/10.1016\/j.coemr.2020.04.005","journal-title":"Curr Opin Endocr Metab Res"},{"issue":"16","key":"11081_CR74","doi-asserted-by":"publisher","first-page":"E3334","DOI":"10.1073\/pnas.1616467114","volume":"114","author":"ASL Caldwell","year":"2017","unstructured":"Caldwell ASL, Edwards MC, Desai R, Jimenez M, Gilchrist RB, Handelsman DJ, Walters KA (2017) Neuroendocrine androgen action is a key extraovarian mediator in the development of polycystic ovary syndrome. Proc Natl Acad Sci USA 114(16):E3334\u2013E3343. https:\/\/doi.org\/10.1073\/pnas.1616467114","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl 1","key":"11081_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-025-01353-8","volume":"23","author":"M Longo","year":"2025","unstructured":"Longo M, Liuzzi F, De Carlini S et al (2025) The role of LH in follicle development: from physiology to new clinical implications. Reprod Biol Endocrinol 23(Suppl 1):22. https:\/\/doi.org\/10.1186\/s12958-025-01353-8","journal-title":"Reprod Biol Endocrinol"},{"issue":"2","key":"11081_CR76","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1172\/JCI114745","volume":"86","author":"JF Cara","year":"1990","unstructured":"Cara JF, Fan J, Azzarello J, Rosenfield RL (1990) Insulin-like growth factor-I enhances luteinizing hormone binding to rat ovarian theca-interstitial cells. J Clin Invest 86(2):560\u2013565. https:\/\/doi.org\/10.1172\/JCI114745","journal-title":"J Clin Invest"},{"issue":"5","key":"11081_CR77","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.cmet.2005.04.001","volume":"1","author":"SA Aparicio","year":"2005","unstructured":"Aparicio SA (2005) Kisspeptins and GPR54\u2013the new biology of the mammalian GnRH axis. Cell Metab 1(5):293\u2013296. https:\/\/doi.org\/10.1016\/j.cmet.2005.04.001","journal-title":"Cell Metab"},{"issue":"10","key":"11081_CR78","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.tins.2007.08.001","volume":"30","author":"AS Kauffman","year":"2007","unstructured":"Kauffman AS, Clifton DK, Steiner RA (2007) Emerging ideas about kisspeptin- GPR54 signaling in the neuroendocrine regulation of reproduction. Trends Neurosci 30(10):504\u2013511. https:\/\/doi.org\/10.1016\/j.tins.2007.08.001","journal-title":"Trends Neurosci"},{"issue":"3","key":"11081_CR79","doi-asserted-by":"publisher","first-page":"E520","DOI":"10.1152\/ajpendo.90895.2008","volume":"296","author":"F Gayt\u00e1n","year":"2009","unstructured":"Gayt\u00e1n F, Gayt\u00e1n M, Castellano JM, Romero M, Roa J, Aparicio B, Garrido N, S\u00e1nchez-Criado JE, Millar RP, Pellicer A, Fraser HM, Tena-Sempere M (2009) KiSS-1 in the mammalian ovary: distribution of Kisspeptin in human and marmoset and alterations in KiSS-1 mRNA levels in a rat model of ovulatory dysfunction. Am J Physiol Endocrinol Metab 296(3):E520\u2013E531. https:\/\/doi.org\/10.1152\/ajpendo.90895.2008","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"9","key":"11081_CR80","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.1210\/en.2016-1354","volume":"157","author":"X Qi","year":"2016","unstructured":"Qi X, Salem M, Zhou W, Sato-Shimizu M, Ye G, Smitz J, Peng C (2016) Neurokinin B exerts direct effects on the ovary to stimulate estradiol production. Endocrinology 157(9):3355\u20133365. https:\/\/doi.org\/10.1210\/en.2016-1354","journal-title":"Endocrinology"},{"issue":"4","key":"11081_CR81","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.fertnstert.2020.05.006","volume":"114","author":"V Blasco","year":"2020","unstructured":"Blasco V, Pinto FM, Fern\u00e1ndez-Atucha A, Gonz\u00e1lez-Ravina C, Fern\u00e1ndez-S\u00e1nchez M, Candenas L (2020) Female infertility is associated with an altered expression of the neurokinin B\/neurokinin B receptor and kisspeptin\/kisspeptin receptor systems in ovarian granulosa and cumulus cells. Fertil Steril 114(4):869\u2013878. https:\/\/doi.org\/10.1016\/j.fertnstert.2020.05.006","journal-title":"Fertil Steril"},{"issue":"5","key":"11081_CR82","doi-asserted-by":"publisher","first-page":"395","DOI":"10.18502\/ijrm.v22i5.16440","volume":"22","author":"A Hestiantoro","year":"2024","unstructured":"Hestiantoro A, Al Maghfira N, Fathmasari R, Rahmala Febri R, Ongko Joyo R, Muharam E, Pratama R, G., Bowolaksono A (2024) Altered expression of kisspeptin, dynorphin, and related neuropeptides in polycystic ovary syndrome: A cross-sectional study. Int J Reproductive Biomed 22(5):395\u2013404. https:\/\/doi.org\/10.18502\/ijrm.v22i5.16440","journal-title":"Int J Reproductive Biomed"},{"key":"11081_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105689","volume":"115","author":"EG Mills","year":"2025","unstructured":"Mills EG, Silva MSB, Delli V, Decoster L, Ternier G, Tsoutsouki J, Thurston L, Phylactou M, Patel B, Yang L, Clarke SA, Young M, Alexander EC, Nyunt S, Yeung AC, Choudhury M, Newman A, Bech P, Abbara A, Swedrowska M, Forbes B, Pr\u00e9vot V, Chachlaki K, Giacobini P, Comninos AN, Dhillo WS (2025) Intranasal kisspeptin administration rapidly stimulates gonadotropin release in humans. EBioMedicine 115:105689. https:\/\/doi.org\/10.1016\/j.ebiom.2025.105689","journal-title":"EBioMedicine"},{"issue":"4","key":"11081_CR84","doi-asserted-by":"publisher","first-page":"R193","DOI":"10.1530\/REP-14-0517","volume":"149","author":"KA Walters","year":"2015","unstructured":"Walters KA (2015) Role of androgens in normal and pathological ovarian function. Reprod (Cambridge England) 149(4):R193\u2013R218. https:\/\/doi.org\/10.1530\/REP-14-0517","journal-title":"Reprod (Cambridge England)"},{"issue":"1","key":"11081_CR85","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.fertnstert.2009.03.004","volume":"94","author":"V Desforges-Bullet","year":"2010","unstructured":"Desforges-Bullet V, Gallo C, Lefebvre C, Pigny P, Dewailly D, Catteau-Jonard S (2010) Increased anti-M\u00fcllerian hormone and decreased FSH levels in follicular fluid obtained in women with polycystic ovaries at the time of follicle puncture for in vitro fertilization. Fertil Steril 94(1):198\u2013204. https:\/\/doi.org\/10.1016\/j.fertnstert.2009.03.004","journal-title":"Fertil Steril"},{"key":"11081_CR86","doi-asserted-by":"publisher","first-page":"10055","DOI":"10.1038\/ncomms10055","volume":"7","author":"I Cimino","year":"2016","unstructured":"Cimino I, Casoni F, Liu X, Messina A, Parkash J, Jamin SP, Catteau-Jonard S, Collier F, Baroncini M, Dewailly D, Pigny P, Prescott M, Campbell R, Herbison AE, Prevot V, Giacobini P (2016) Novel role for anti-M\u00fcllerian hormone in the regulation of GnRH neuron excitability and hormone secretion. Nat Commun 7:10055. https:\/\/doi.org\/10.1038\/ncomms10055","journal-title":"Nat Commun"},{"issue":"1","key":"11081_CR87","doi-asserted-by":"publisher","first-page":"8229","DOI":"10.1038\/s41598-024-58064-0","volume":"14","author":"G Pratama","year":"2024","unstructured":"Pratama G, Wiweko B, Asmarinah, Widyahening IS, Andraini T, Bayuaji H, Hestiantoro A (2024) Mechanism of elevated LH\/FSH ratio in lean PCOS revisited: a path analysis. Sci Rep 14(1):8229. https:\/\/doi.org\/10.1038\/s41598-024-58064-0","journal-title":"Sci Rep"},{"issue":"8","key":"11081_CR88","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1210\/js.2019-00078","volume":"3","author":"SF Witchel","year":"2019","unstructured":"Witchel SF, Oberfield SE, Pe\u00f1a AS (2019) Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls. J Endocr Soc 3(8):1545\u20131573. https:\/\/doi.org\/10.1210\/js.2019-00078","journal-title":"J Endocr Soc"},{"issue":"8","key":"11081_CR89","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1210\/en.2010-0022","volume":"151","author":"MN Lehman","year":"2010","unstructured":"Lehman MN, Coolen LM, Goodman RL (2010) Minireview: kisspeptin\/neurokinin B\/dynorphin (KNDy) cells of the arcuate nucleus: a central node in the control of gonadotropin-releasing hormone secretion. Endocrinology 151(8):3479\u20133489. https:\/\/doi.org\/10.1210\/en.2010-0022","journal-title":"Endocrinology"},{"issue":"10","key":"11081_CR90","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1210\/en.2019-00428","volume":"160","author":"A Ruddenklau","year":"2019","unstructured":"Ruddenklau A, Campbell RE (2019) Neuroendocrine impairments of polycystic ovary syndrome. Endocrinology 160(10):2230\u20132242. https:\/\/doi.org\/10.1210\/en.2019-00428","journal-title":"Endocrinology"},{"issue":"6","key":"11081_CR91","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/j.cmet.2019.02.012","volume":"29","author":"F Sacco","year":"2019","unstructured":"Sacco F, Seelig A, Humphrey SJ, Krahmer N, Volta F, Reggio A, Marchetti P, Gerdes J, Mann M (2019) Phosphoproteomics reveals the GSK3-PDX1 axis as a key pathogenic signaling node in diabetic islets. Cell Metab 29(6):1422-1432e3. https:\/\/doi.org\/10.1016\/j.cmet.2019.02.012","journal-title":"Cell Metab"},{"issue":"4","key":"11081_CR92","doi-asserted-by":"publisher","first-page":"T131","DOI":"10.1530\/ERC-13-0472","volume":"21","author":"Y Koryakina","year":"2014","unstructured":"Koryakina Y, Ta HQ, Gioeli D (2014) Androgen receptor phosphorylation: biological context and functional consequences. Endocrine-related Cancer 21(4):T131\u2013T145. https:\/\/doi.org\/10.1530\/ERC-13-0472","journal-title":"Endocrine-related Cancer"},{"key":"11081_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2020.02.065","author":"CJ Yu","year":"2020","unstructured":"Yu CJ, Liu X, Zhou ZY, Chen XJ, Meng YC, Gu HC, Xu JJ, Ding GL, Liu XM, Sheng JZ, Huang HF (2020) The casein kinase 2\u03b1 promotes the occurrence polycystic ovary syndrome. Biochem Biophys Res Commun. https:\/\/doi.org\/10.1016\/j.bbrc.2020.02.065","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"11081_CR94","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00404-016-4068-z","volume":"294","author":"S Mikaeili","year":"2016","unstructured":"Mikaeili S, Rashidi BH, Safa M, Najafi A, Sobhani A, Asadi E, Abbasi M (2016) Altered FoxO3 expression and apoptosis in granulosa cells of women with polycystic ovary syndrome. Arch Gynecol Obstet 294(1):185\u2013192. https:\/\/doi.org\/10.1007\/s00404-016-4068-z","journal-title":"Arch Gynecol Obstet"},{"issue":"6","key":"11081_CR95","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1182\/blood-2011-07-369728","volume":"120","author":"KK Hosszu","year":"2012","unstructured":"Hosszu KK, Valentino A, Vinayagasundaram U, Vinayagasundaram R, Joyce MG, Ji Y, Peerschke EI, Ghebrehiwet B (2012) DC-SIGN, C1q, and gC1qR form a trimolecular receptor complex on the surface of monocyte-derived immature dendritic cells. Blood 120(6):1228\u20131236. https:\/\/doi.org\/10.1182\/blood-2011-07-369728","journal-title":"Blood"},{"issue":"4","key":"11081_CR96","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41573-020-00108-x","volume":"20","author":"KP Bhat","year":"2021","unstructured":"Bhat KP, \u00dcmit Kaniskan H, Jin J, Gozani O (2021) Epigenetics and beyond: targeting writers of protein lysine methylation to treat disease. Nat Rev Drug Discov 20(4):265\u2013286. https:\/\/doi.org\/10.1038\/s41573-020-00108-x","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"11081_CR97","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073804","volume":"23","author":"M Adamczyk","year":"2022","unstructured":"Adamczyk M, Wender-Ozegowska E, Kedzia M (2022) Epigenetic factors in eutopic endometrium in women with endometriosis and infertility. Int J Mol Sci 23(7):3804. https:\/\/doi.org\/10.3390\/ijms23073804","journal-title":"Int J Mol Sci"},{"issue":"9","key":"11081_CR98","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1038\/s41418-018-0067-x","volume":"25","author":"Z Sun","year":"2018","unstructured":"Sun Z, Zhang H, Wang X, Wang QC, Zhang C, Wang JQ, Wang YH, An CQ, Yang KY, Wang Y, Gao F, Guo C, Tang TS (2018) TMCO1 is essential for ovarian follicle development by regulating ER Ca2+ store of granulosa cells. Cell Death Differ 25(9):1686\u20131701. https:\/\/doi.org\/10.1038\/s41418-018-0067-x","journal-title":"Cell Death Differ"},{"issue":"11","key":"11081_CR99","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1080\/14789450.2021.2007766","volume":"18","author":"O Morales-Tarr\u00e9","year":"2021","unstructured":"Morales-Tarr\u00e9 O, Alonso-Bastida R, Arcos-Encarnaci\u00f3n B, P\u00e9rez-Mart\u00ednez L, Encarnaci\u00f3n-Guevara S (2021) Protein lysine acetylation and its role in different human pathologies: a proteomic approach. Expert Rev Proteomics 18(11):949\u2013975. https:\/\/doi.org\/10.1080\/14789450.2021.2007766","journal-title":"Expert Rev Proteomics"},{"issue":"12","key":"11081_CR100","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1071\/RD16428","volume":"29","author":"F Eini","year":"2017","unstructured":"Eini F, Novin MG, Joharchi K, Hosseini A, Nazarian H, Piryaei A, Bidadkosh A (2017) Intracytoplasmic oxidative stress reverses epigenetic modifications in polycystic ovary syndrome. Reprod Fertil Dev 29(12):2313\u20132323. https:\/\/doi.org\/10.1071\/RD16428","journal-title":"Reprod Fertil Dev"},{"issue":"6","key":"11081_CR101","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1093\/humrep\/deac069","volume":"37","author":"M Cozzolino","year":"2022","unstructured":"Cozzolino M, Herraiz S, Titus S, Roberts L, Romeu M, Peinado I, Scott RT, Pellicer A, Seli E (2022) Transcriptomic landscape of granulosa cells and peripheral blood mononuclear cells in women with PCOS compared to young poor responders and women with normal response. Hum Reprod (Oxford England) 37(6):1274\u20131286. https:\/\/doi.org\/10.1093\/humrep\/deac069","journal-title":"Hum Reprod (Oxford England)"},{"key":"11081_CR102","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13048-015-0158-y","volume":"8","author":"S Zhao","year":"2015","unstructured":"Zhao S, Tian Y, Zhang W, Xing X, Li T, Liu H, Huang T, Ning Y, Zhao H, Chen ZJ (2015) An association study between USP34 and polycystic ovary syndrome. J Ovarian Res 8:30. https:\/\/doi.org\/10.1186\/s13048-015-0158-y","journal-title":"J Ovarian Res"},{"issue":"1","key":"11081_CR103","doi-asserted-by":"publisher","first-page":"10272","DOI":"10.1038\/s41598-017-09880-0","volume":"7","author":"JJ Lim","year":"2017","unstructured":"Lim JJ, Lima PDA, Salehi R, Lee DR, Tsang BK (2017) Regulation of androgen receptor signaling by ubiquitination during folliculogenesis and its possible dysregulation in polycystic ovarian syndrome. Sci Rep 7(1):10272. https:\/\/doi.org\/10.1038\/s41598-017-09880-0","journal-title":"Sci Rep"},{"key":"11081_CR104","doi-asserted-by":"publisher","first-page":"1024320","DOI":"10.3389\/fendo.2022.1024320","volume":"13","author":"H Wei","year":"2022","unstructured":"Wei H, Huo P, Liu S, Huang H, Zhang S (2022) Posttranslational modifications in pathogenesis of PCOS. Front Endocrinol 13:1024320. https:\/\/doi.org\/10.3389\/fendo.2022.1024320","journal-title":"Front Endocrinol"},{"issue":"11","key":"11081_CR105","doi-asserted-by":"publisher","first-page":"e1844","DOI":"10.7759\/cureus.1844","volume":"9","author":"F Saleem","year":"2017","unstructured":"Saleem F, Rizvi SW (2017) New therapeutic approaches in obesity and metabolic syndrome associated with polycystic ovary syndrome. Cureus 9(11):e1844. https:\/\/doi.org\/10.7759\/cureus.1844","journal-title":"Cureus"},{"issue":"3","key":"11081_CR106","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1530\/JOE-14-0711","volume":"226","author":"A Diane","year":"2015","unstructured":"Diane A, Kupreeva M, Borthwick F, Proctor SD, Pierce WD, Vine DF (2015) Cardiometabolic and reproductive benefits of early dietary energy restriction and voluntary exercise in an obese PCOS-prone rodent model. J Endocrinol 226(3):193\u2013206. https:\/\/doi.org\/10.1530\/JOE-14-0711","journal-title":"J Endocrinol"},{"issue":"1","key":"11081_CR107","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2025.2477295","volume":"57","author":"T Wu","year":"2025","unstructured":"Wu T, Liu Y, Kong F, Hu J, Liu Y, Yang J, Chen J (2025) Improvement of endocrine and metabolic conditions in patients with polycystic ovary syndrome through acupuncture and its combined therapies: a systematic review and meta-analysis. Ann Med 57(1):2477295. https:\/\/doi.org\/10.1080\/07853890.2025.2477295","journal-title":"Ann Med"},{"issue":"6","key":"11081_CR108","first-page":"1185","volume":"20","author":"B Yang","year":"2016","unstructured":"Yang B, Sun ZJ, Chen B, Zhang J, Zhao H, Li CW, Cao YK, Cao F (2016) Statin ameliorates endothelial dysfunction and insulin resistance in Tibet women with polycystic ovary syndrome. Eur Rev Med Pharmacol Sci 20(6):1185\u20131191","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"11081_CR109","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12958-023-01055-z","volume":"21","author":"D Greff","year":"2023","unstructured":"Greff D, Juh\u00e1sz AE, V\u00e1ncsa S et al (2023) Inositol is an effective and safe treatment in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Reprod Biol Endocrinol 21:10. https:\/\/doi.org\/10.1186\/s12958-023-01055-z","journal-title":"Reprod Biol Endocrinol"},{"key":"11081_CR110","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s13098-025-01730-8","volume":"17","author":"K Sridharan","year":"2025","unstructured":"Sridharan K, Sivaramakrishnan G (2025) Expanding therapeutic horizons: glucagon-like peptide-1 receptor agonists and sodium glucose transporter-2 inhibitors in poly cystic ovarian syndrome: a comprehensive review including systematic review and network meta-analysis of randomized clinical trials. Diabetol Metab Syndr 17:168. https:\/\/doi.org\/10.1186\/s13098-025-01730-8","journal-title":"Diabetol Metab Syndr"},{"key":"11081_CR111","doi-asserted-by":"publisher","unstructured":"Izquierdo D, Foyouzi N, Kwintkiewicz J, Duleba AJ (2004) Mevastatin inhibits ovarian theca-interstitial cell proliferation and steroidogenesis. Fertility Steril 82 Suppl 31193\u20131197. https:\/\/doi.org\/10.1016\/j.fertnstert.2004.03.037","DOI":"10.1016\/j.fertnstert.2004.03.037"},{"issue":"2","key":"11081_CR112","doi-asserted-by":"publisher","first-page":"134","DOI":"10.2174\/1574888X18666230517123256","volume":"19","author":"HR Nejabati","year":"2024","unstructured":"Nejabati HR, Nikzad S, Roshangar L (2024) Therapeutic potential of mesenchymal stem cells in PCOS. Curr Stem Cell Res Ther 19(2):134\u2013144. https:\/\/doi.org\/10.2174\/1574888X18666230517123256","journal-title":"Curr Stem Cell Res Ther"},{"key":"11081_CR113","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13048-025-01660-z","volume":"18","author":"P Mallya","year":"2025","unstructured":"Mallya P, Lewis SA (2025) Curcumin and its formulations for the treatment of polycystic ovary syndrome: current insights and future prospects. J Ovarian Res 18:78. https:\/\/doi.org\/10.1186\/s13048-025-01660-z","journal-title":"J Ovarian Res"},{"issue":"1","key":"11081_CR114","doi-asserted-by":"publisher","first-page":"85","DOI":"10.5935\/1518-0557.20220024","volume":"27","author":"A Manouchehri","year":"2023","unstructured":"Manouchehri A, Abbaszadeh S, Ahmadi M, Nejad FK, Bahmani M, Dastyar N (2023) Polycystic ovaries and herbal remedies: a systematic review. JBRA Assist Reprod 27(1):85\u201391. https:\/\/doi.org\/10.5935\/1518-0557.20220024","journal-title":"JBRA Assist Reprod"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11081-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-11081-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11081-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T05:04:28Z","timestamp":1766898268000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-11081-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,4]]},"references-count":114,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["11081"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-11081-2","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,4]]},"assertion":[{"value":"15 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.\u00a0","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Sources of support"}}],"article-number":"980"}}